Skip to main content
SpringerLink
Log in

No serious safety concerns with early drug approval

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Arnardottir AH, Haaijer-Ruskamp FM, Straus SM, Eichler HG, de Graeff PA, Mol PG.Additional safety risk to exceptionally approved drugs in Europe? British Journal of Clinical Pharmacology: 18 Apr 2011. Available from: URL: http://dx.doi.org/10.1111/j.1365-2125.2011.03995.x

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

No serious safety concerns with early drug approval. React. Wkly. 1354, 3 (2011). https://doi.org/10.2165/00128415-201113540-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113540-00007

Keywords

Search

Navigation